Sacramento doctor: If not for NIH funding, I wouldn’t have survived my leukemia diagnosis | Opinion
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
The American Journal of Managed Care1d
Neutrophil Subset Changes Give Insight Into First Mechanisms of MDS, AML
The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density neutrophil subsets in myelodysplastic syndromes (MDS), acute myeloid leukemia ...
Targeted Oncology1d
Organ-Sparing TMLI Enhances AML Transplant Outcomes
Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...
Using machine learning tools to detect gene mutations from leukemia cell images
Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...
Clinical Trials Arena on MSN1d
Cantargia enrols first patient in trial of nadunolimab for AML and MDS
Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in ...
Bionano Genomics announces publication reporting first use of OGM to detect CAG
Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome ...
Endocrinology Advisor2d
Study Reveals Link Between Forever Chemicals and Childhood Cancers
There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers.
Targeted Oncology2d
Actimab-A Triplet Trial Launches in Frontline AML
Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...
Robert Wayne Compton, Youngstown, Ohio
YOUNGSTOWN, Ohio (MyValleyTributes) – Robert Wayne Compton, 73, passed away Thursday March 6, 2025 at St. Elizabeth Hospital ...
Knowridge Science Report5d
New drug combo could fight aggressive blood cancer
Researchers from Karl Landsteiner University of Health Sciences (KL Krems) have discovered that combining two existing drugs ...
Medscape8d
AML: Monitor Early Measurable Residual Disease to Optimize Outcomes
Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.